AUG 04, 2019 8:04 AM PDT

The anti-cancer flower

Perhaps you have heard of feverfew, a quite common flowering plant that graces many home gardens. Its cute white petals may bring a smile to your lips – but did you know that it has hidden within it an anti-cancer compound?

New research from the University of Birmingham and published in MedChemComm shows that in addition to acting as a natural remedy for fevers, migraine headaches, rheumatoid arthritis, stomach aches, and toothaches, among other symptoms, feverfew is also capable of killing chronic lymphocytic leukaemia (CLL) cells.

Researchers from the University's Institute of Cancer and Genomic Studies, the School of Chemistry and the drug discovery services companies, Sygnature Discovery and Apconix collaborated with the University of Birmingham's Winterbourne Botanic Garden to cultivate enough feverfew plants to conduct the study. While previous studies had identified the compound found in the plant, called parthenolide, it is currently only available commercially at an outrageously high price and still not very effective.

The research team wanted to change that so they set out to find a way to produce the parthenolide directly from plants, as well as a way to alter it so that the plant produces several other compounds that were shown to kill cancer cells in in vitro experiments. While still only demonstrated in a laboratory setting, the finding could have significant impacts on development of treatments for chronic lymphocytic leukaemia (CLL) therapies.

A researcher on the study, Dr. Angelo Agathanggelou, of the Institute of Cancer and Genomic Studies, clarified: "There are several effective treatments for CLL, but after a time the disease in some patients becomes resistant. We were interested in finding out more about the potential of parthenolide. With expertise from colleagues in the School of Chemistry we've been able to demonstrate that this compound shows real promise and could provide alternative treatment options for CLL patients."

Inside feverfew hides a compound with anti-cancer properties. Photo: Pixabay

Another researcher on the study, Professor John Fossey, commented: "This research is important not only because we have shown a way of producing parthenolide that could make it much more accessible to researchers, but also because we've been able to improve its "drug-like" properties to kill cancer cells. It's a clear demonstration that parthenolide has the potential to progress from the flowerbed into the clinic."

Parthenolide works by raising the levels of reactive oxygen species (ROS) in cells, essentially pushing ROS levels to an unsustainable level in cancer cells until the cell cannot survive and dies.

Sources: Science Daily, MedChemComm

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
MAR 17, 2020
Cancer
MAR 17, 2020
Cancer and the risk of AFib
Research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of ...
MAR 24, 2020
Clinical & Molecular DX
MAR 24, 2020
Ultra sensitive cancer diagnostic detects DNA "fingerprints" in liquid biopsies
  Researchers from the Broad and Dana-Farber Cancer Institutes have developed a diagnostic technology that can moni ...
MAR 18, 2020
Drug Discovery & Development
MAR 18, 2020
Drug Could Effectively Treat a Lethal Blood Cancer
A pricey drug, called tyrosine kinase inhibitor (TKI), is used to continuously treat the blood cancer Chronic Myeloid Le ...
APR 06, 2020
Cancer
APR 06, 2020
A New Lead in the Treatment of Hepatocellular Carcinomas
  Hepatocellular carcinoma, or HCC, is a type of liver cancer, and the third most prevalent cancer-caused death in ...
APR 09, 2020
Cancer
APR 09, 2020
The Unexpected Anti-Cancer Effects of the Human Telomerase
The research to find effective treatments and diagnosing tools in the fight against cancer has led to a thorough investi ...
MAY 28, 2020
Cancer
MAY 28, 2020
The Oncogenic Hazard of a Potential Alzheimer's Treatment
Breast cancer remains one of the most common cancers around the world. Triple-Negative Breast Cancer (TNBC) is a sub-typ ...
Loading Comments...